BIAF · bioAffinity Technologies, Inc.
$0.40
+0.02 (+4.99%)
At close · Aug 14
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's current expected level of operating expenditures and the cash and cash equivalents on hand at June 30, 2026, management concludes that there is substantial doubt about the Company's ability to continue as a going concern for a period of at least twelve (12) months subsequent to the issuance of the accompanying unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 7, 2026
Market Cap
$3.26M
Shares
8.10M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-05-22 | — | $5,801,000 | — | — | 10-Q , filed 2025-08-14 |
Key facts
CIK
1712762
CUSIP
09076W307
13F (30d)
21 filings
21 filers
Visit website
Investor relations